AC
Allstate Corporation Portfolio holdings
AUM
$1.39B
This Quarter Return
+3.13%
1 Year Return
+12.46%
3 Year Return
+31.31%
5 Year Return
+54.76%
10 Year Return
+118.15%
AUM
$3.19B
AUM Growth
-$33.9M
(-1.1%)
Cap. Flow
-$143M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
54.31%
Holding
755
New
52
Increased
441
Reduced
146
Closed
31
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 7.75% |
| 2 | Financials | 5.61% |
| 3 | Healthcare | 4.86% |
| 4 | Consumer Discretionary | 4.34% |
| 5 | Industrials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
151
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.05M | 0.06% |
26,977
+1,016
| +4% | +$77.1K |
|
152
Moody's
MCO
$89B
| $2.04M | 0.06% |
6,827
+934
| +16% | +$279K |
|
153
Altria Group
MO
$112B
| $2.04M | 0.06% |
39,823
+3,738
| +10% | +$191K |
|
154
Becton Dickinson
BDX
$54.3B
| $2.03M | 0.06% |
8,540
+1,905
| +29% | +$452K |
|
155
Portland General Electric
POR
$4.68B
| $2.02M | 0.06% |
42,623
+3,644
| +9% | +$173K |
|
156
Marsh & McLennan
MMC
$101B
| $2.02M | 0.06% |
16,585
+259
| +2% | +$31.5K |
|
157
Q2 Holdings
QTWO
$4.83B
| $2.02M | 0.06% |
20,161
+553
| +3% | +$55.4K |
|
158
Aon
AON
$80.6B
| $1.99M | 0.06% |
8,631
+470
| +6% | +$108K |
|
159
CubeSmart
CUBE
$9.31B
| $1.98M | 0.06% |
52,324
+2,573
| +5% | +$97.3K |
|
160
Charles Schwab
SCHW
$175B
| $1.97M | 0.06% |
30,254
+5,049
| +20% | +$329K |
|
161
Woodward
WWD
$14.7B
| $1.97M | 0.06% |
16,330
-535
| -3% | -$64.5K |
|
162
ICU Medical
ICUI
$3.06B
| $1.95M | 0.06% |
9,483
+1,768
| +23% | +$363K |
|
163
Healthpeak Properties
DOC
$12.3B
| $1.93M | 0.06% |
60,861
-18,039
| -23% | -$573K |
|
164
Wintrust Financial
WTFC
$9.16B
| $1.93M | 0.06% |
25,419
-883
| -3% | -$66.9K |
|
165
NNN REIT
NNN
$8.03B
| $1.93M | 0.06% |
43,687
+1,532
| +4% | +$67.5K |
|
166
PNC Financial Services
PNC
$80.7B
| $1.92M | 0.06% |
10,924
+888
| +9% | +$156K |
|
167
LCI Industries
LCII
$2.5B
| $1.9M | 0.06% |
14,320
| – | – |
|
168
Newmont
NEM
$82.8B
| $1.89M | 0.06% |
31,362
+6,803
| +28% | +$410K |
|
169
Boston Scientific
BSX
$159B
| $1.87M | 0.06% |
48,262
+5,612
| +13% | +$217K |
|
170
Carter's
CRI
$1.04B
| $1.86M | 0.06% |
20,920
+2,904
| +16% | +$258K |
|
171
Edwards Lifesciences
EW
$47.7B
| $1.86M | 0.06% |
22,183
+537
| +2% | +$44.9K |
|
172
Crown Castle
CCI
$42.3B
| $1.85M | 0.06% |
10,759
+352
| +3% | +$60.6K |
|
173
Quaker Houghton
KWR
$2.34B
| $1.84M | 0.06% |
7,555
| – | – |
|
174
Vertex Pharmaceuticals
VRTX
$102B
| $1.84M | 0.06% |
8,546
+2,111
| +33% | +$454K |
|
175
Lockheed Martin
LMT
$105B
| $1.83M | 0.06% |
4,939
-383
| -7% | -$142K |
|